Form 4 for LUNG Pulmonx Corp
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001415889-24-006846 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-05 | 2024-03-01 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | A - Grant | $0.00 | +34.5K | 274.5K | +14% | $0 |
| DM | 2024-03-05 | 2024-03-01 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $9.06 | -3,097 | 242.6K | -1% | -$28.1K |
| D | 2024-03-05 | 2024-03-01 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | A - Grant | $0.00 | +69.1K | 69.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | A | A | 34,500 | $0.00 | 274,452 | D | — | — | (F4) Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024. |
| 2 | Common | Common Stock | 2024-03-01 | S | D | 1,916 | $9.06 | 239,952 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-01 | S | D | 753 | $9.06 | 241,868 | D | — | — | |
| 4 | Common | Common Stock | 2024-03-01 | S | D | 428 | $9.06 | 242,621 | D | — | — | |
| 5 | Derivative | Employee Stock Option (right to buy) | 2024-03-01 | A | A | 69,100 | $0.00 | 69,100 | D | $9.30 · — to 2034-02-28 | 69,100 Common Stock | (F5) The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024. |